Report #2837048

Received Apr 21, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (ENGERIX-B)	GLAXOSMITHKLINE BIOLOGICALS	3	UNK	—

Symptoms (1)

Inappropriate schedule of product administration

Symptom narrative

got the 3rd vaccine in 5 months; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of drug dose administration interval too short in a patient who received HBV (Engerix B) for prophylaxis. On an unknown date, the patient received the 3rd dose of Engerix B. On an unknown date, an unknown time after receiving Engerix B, the patient experienced drug dose administration interval too short (Verbatim: got the 3rd vaccine in 5 months). The outcome of the drug dose administration interval too short was not applicable. Additional Information: GSK Receipt Date: 15-APR-2025 The patient self reported this case for himself/herself This case was reported by a patient via interactive digital media. Patient was taking the series of Hepatitis B (Recombinant) Engerix-B vaccine. He/she had gotten the third vaccine in 5 months, which led to shortening of vaccination schedule.